Filtricine research on scientific conference for cancer treatment
- Xiyan Li
- Nov 1, 2019
- 1 min read
Updated: Mar 14, 2022
At the AACR-NCI-EORTC conference for molecular targets (#Targets19) at Boston, we presented our latest preclinical research on treating colon cancer and boosting anti-PD-1 immunotherapy with our “targeted nutrient deprivation” technology.
Comments